MoonLake Immunotherapeutics (MLTX) Fundamentals

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
SHARE INFORMATION
Market Cap$ 286,542,959
Shares Outstanding36,925,639
Float10,618,020
Percent Float28.76%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.45
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions38
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months771,461
Institutional Holdings Percent103.7%
Institutional Sold Previous 3 Months22,857
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months-
Insider Holdings Percent4.1
Insider Sold Previous 3 Months-
Insider Shares Owned1,520,334
TRADING INFO
52 Week High$ 15.19
52 Week Low$ 4.25
52 Week High Change$ -22.01
21 Day Moving Average$ 7.6544
21 Day Extended Moving Average$ 7.6335
50 Day Moving Average$ 7.4132
50 Day Extended Moving Average$ 7.3627
200 Day Moving Average$ 7.8784
200 Day Extended Moving Average$ 7.7234
10 Day Average Volume9,899
20 Day Average Volume20,268
30 Day Average Volume30,570
50 Day Average Volume52,604
Alpha-0.010831
Beta1.3499
Standard Deviation0.155620
R20.203939
7 Day Price Change$ 0.45
7 Day Percent Change6.16%
21 Day Price Change$ 0.06
21 Day Percent Change0.78%
30 Day Price Change$ -0.30
30 Day Percent Change-3.72%
Month to Date Price Change$ -0.30
Month to Date Percent Change-3.72%
Quarter to Date Price Change$ 2.51
Quarter to Date Percent Change47.81%
180 Day Price Change$ -3.34
180 Day Percent Change-30.09%
200 Day Price Change$ -2.19
200 Day Percent Change-22.01%
Year to Date Price Change$ -2.13
Year to Date Percent Change-21.54%

MoonLake Immunotherapeutics (MLTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.50
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio25.50
Leverage Ratio2.10
Quick Ratio24.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-3.50
Enterprise Value$ 293,576,579
Price to Sales0.00
Price to Free Cash-6.40
PE High Last 5 Years0.00
Price To Book1.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book4.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-54.76
Return on Equity-84.87
Return on Capital-128.56

MoonLake Immunotherapeutics (MLTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOJorge Santos da Silva
Emplyoees-
Last Audit-
CIK0001821586
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in the Social Sciences and Humanities(541720)
CONTACT INFO
AddressDorfstrasse 29
Zug, 6300
Websitehttps://www.moonlaketx.com
Facsimile-
Telephone-
Email-


Your Recent History
NASDAQ
MLTX
MoonLake I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.